{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:40:18Z","timestamp":1738921218820,"version":"3.37.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00393-008-0425-z","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T08:09:05Z","timestamp":1233302945000},"page":"49-64","source":"Crossref","is-referenced-by-count":6,"title":["Wegener-Granulomatose und mikroskopische Polyangiitis","Wegener\u2019s granulomatosis and microscopic polyangiitis"],"prefix":"10.1007","volume":"68","author":[{"given":"K.","family":"de Groot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Reinhold-Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"key":"425_CR1","first-page":"202","volume":"29","author":"Wegener","year":"1936","unstructured":"Wegener F (1936) \u00dcber generalisierte septische Gef\u00e4\u00dferkrankung. Verh Dtsch Ges Path 29:202\u2013210","journal-title":"Verh Dtsch Ges Path"},{"key":"425_CR2","first-page":"377","volume":"246","author":"Wohlwill","year":"1923","unstructured":"Wohlwill F (1923) \u00dcber die nur mikroskopisch erkennbare Form der Periarteriitis nodosa. Virchows Archiv f\u00fcr Pathologische Anatomie und Physiologie und f\u00fcr Klinische Medizin 246:377\u2013411","journal-title":"Virchows Archiv f\u00fcr Pathologische Anatomie und Physiologie und f\u00fcr Klinische Medizin"},{"key":"425_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: The proposal of an International Consensus Conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"425_CR4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"425_CR5","first-page":"355","volume":"105","author":"Herlyn","year":"2008","unstructured":"Herlyn K, Hellmich B, Gross WL, Reinhold-Keller E (2008) Stable incidence of systemic vasculitides in Schleswig-Holstein, Germany. Dtsch Arztebl Int 105:355\u2013361","journal-title":"Dtsch Arztebl Int"},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","volume":"53","author":"Reinhold-Keller","year":"2005","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93\u201399","journal-title":"Arthritis Rheum"},{"key":"425_CR7","doi-asserted-by":"crossref","unstructured":"Mohammad AJ, Jacobsson LT, Mahr AD et al (2007) Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329\u20131337","DOI":"10.1093\/rheumatology\/kem107"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","volume":"23","author":"Watts","year":"2008","unstructured":"Watts RA, Scott DG, Jayne DR et al (2008) Renal vasculitis in Japan and the UK\u2013are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant 23:3928\u20133931","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR9","doi-asserted-by":"crossref","unstructured":"Ormerod A, Cook M (2008) Epidemiology of primary systemic vasculitis in the australian capital territory and south-eastern New South Wales. Intern Med J [Epub ahead of print Sep 2]","DOI":"10.1111\/j.1445-5994.2008.01672.x"},{"key":"425_CR10","doi-asserted-by":"crossref","unstructured":"Chen M, Yu F, Zhang Y, Zhao MH (2008) Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 87:203\u2013209","DOI":"10.1097\/MD.0b013e31817c744b"},{"key":"425_CR11","first-page":"425","volume":"1","author":"van","year":"1985","unstructured":"van der Woude FJ, Rasmussen N, Lobatto S et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis. Lancet 1:425\u2013429","journal-title":"Lancet"},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(86)91820-9","volume":"328","author":"Gross","year":"1986","unstructured":"Gross WL, L\u00fcdemann G, Kiefer G, Lehmann H (1986) Anticytoplasmic antibodies in Wegener\u2019s granulomatosis. Lancet 328:806","journal-title":"Lancet"},{"key":"425_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","volume":"111","author":"N\u00f6lle","year":"1989","unstructured":"N\u00f6lle B, Specks U, L\u00fcdemann J et al (1989) Anticytoplasmic autoantibodies: Their immunodiagnostic value in wegener\u2019s granulomatosis. Ann Intern Med 111:28\u201340","journal-title":"Ann Intern Med"},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"Hagen","year":"1998","unstructured":"Hagen EC, Daha MR, Hermans J et al (1998) Diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 53:743\u2013753","journal-title":"Kidney Int"},{"key":"425_CR15","doi-asserted-by":"crossref","unstructured":"Schonermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40:178\u2013184","DOI":"10.1093\/rheumatology\/40.2.178"},{"key":"425_CR16","first-page":"280","volume":"149","author":"Gross","year":"1998","unstructured":"Gross WL, Trabandt A, Csernok E (1998) Pathogenesis of Wegener\u2019s granulomatosis. Ann Med Int 149:280\u2013286","journal-title":"Ann Med Int"},{"key":"425_CR17","first-page":"1113","volume":"137","author":"Csernok","year":"1990","unstructured":"Csernok E, L\u00fcdemann J, Gross WL, Bainton DF (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener\u2019s granulomatosis. Am J Pathol 137:1113\u20131120","journal-title":"Am J Pathol"},{"key":"425_CR18","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"Falk","year":"1990","unstructured":"Falk RJ, Terrel RS, Charles LA, Jenette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87:4115\u20134119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"425_CR19","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/j.1523-1755.2004.00640.x","volume":"65","author":"Schreiber","year":"2004","unstructured":"Schreiber A, Luft FC, Kettritz R (2004) Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 65:2172\u20132183","journal-title":"Kidney Int"},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","volume":"14","author":"Schreiber","year":"2003","unstructured":"Schreiber A, Busjahn A, Luft FC, Kettritz R (2003) Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14:68\u201375","journal-title":"J Am Soc Nephrol"},{"key":"425_CR21","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","volume":"10","author":"Witko-Sarsat","year":"1999","unstructured":"Witko-Sarsat V, Lesavre P, Lopez S et al (1999) A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10:1224\u20131233","journal-title":"J Am Soc Nephrol"},{"key":"425_CR22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/01.ASN.0000019411.36000.06","volume":"13","author":"Kettritz","year":"2002","unstructured":"Kettritz R, Choi M, Butt W et al (2002) Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 13:1740\u20131749","journal-title":"J Am Soc Nephrol"},{"key":"425_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.V12137","volume":"12","author":"Kettritz","year":"2001","unstructured":"Kettritz R, Schreiber A, Luft FC, Haller H (2001) Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12:37\u201346","journal-title":"J Am Soc Nephrol"},{"key":"425_CR24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.2005080882","volume":"17","author":"Morgan","year":"2006","unstructured":"Morgan MD, Harper L, Williams J, Savage C (2006) Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 17:1224\u20131234","journal-title":"J Am Soc Nephrol"},{"key":"425_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","volume":"10","author":"Pendergraft","year":"2004","unstructured":"Pendergraft WF 3rd, Preston GA, Shah RR et al (2004) Autoimmunity is triggered by cPR-3(105\u2013201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72\u201379","journal-title":"Nat Med"},{"key":"425_CR26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"Kain","year":"2008","unstructured":"Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088\u20131096","journal-title":"Nat Med"},{"key":"425_CR27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955\u2013963","journal-title":"J Clin Invest"},{"key":"425_CR28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","volume":"45","author":"Schlieben","year":"2005","unstructured":"Schlieben DJ, Korbet SM, Kimura RE et al (2005) Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 45:758\u2013761","journal-title":"Am J Kidney Dis"},{"key":"425_CR29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","volume":"104","author":"Pfister","year":"2004","unstructured":"Pfister H, Ollert M, Frohlich LF et al (2004) Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104:1411\u20131418","journal-title":"Blood"},{"key":"425_CR30","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","volume":"160","author":"Komocsi","year":"2002","unstructured":"Komocsi A, Lamprecht P, Csernok E et al (2002) Peripheral blood and granuloma CD4(+)CD28(\u2013) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener\u2019s granulomatosis. Am J Pathol 160:1717\u20131724","journal-title":"Am J Pathol"},{"key":"425_CR31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2005.02808.x","volume":"141","author":"Lamprecht","year":"2005","unstructured":"Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141:201\u2013210","journal-title":"Clin Exp Immunol"},{"key":"425_CR32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2005.044909","volume":"65","author":"Voswinkel","year":"2006","unstructured":"Voswinkel J, Mueller A, Kraemer JA et al (2006) B lymphocyte maturation in Wegener\u2019s granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 65:859\u2013864","journal-title":"Ann Rheum Dis"},{"key":"425_CR33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.11387","volume":"49","author":"Agard","year":"2003","unstructured":"Agard C, Mouthon L, Mahr A, Guillevin L (2003) Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum 49:709\u2013715","journal-title":"Arthritis Rheum"},{"key":"425_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.10922","volume":"49","author":"Guillevin","year":"2003","unstructured":"Guillevin L, Cohen P, Mahr A et al (2003) Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 49:93\u2013100","journal-title":"Arthritis Rheum"},{"key":"425_CR35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/ard.2005.043638","volume":"65","author":"Watts","year":"2006","unstructured":"Watts R, Lane S, Hanslik T et al (2006) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 65:946\u2013948","journal-title":"Ann Rheum Dis"},{"key":"425_CR36","first-page":"467","volume":"56","author":"Savage","year":"1985","unstructured":"Savage COS, Winearis CG, Evans DJ et al (1985) Microscopic polyarteriitis: presentation, pathology and prognosis. QJM 56:467\u2013483","journal-title":"QJM"},{"key":"425_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/BOR.0b013e3282f370d1","volume":"20","author":"Jayne","year":"2008","unstructured":"Jayne D (2008) Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol 20:3\u20139","journal-title":"Curr Opin Rheumatol"},{"key":"425_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","volume":"9","author":"Homma","year":"2004","unstructured":"Homma S, Matsushita H, Nakata K (2004) Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology Carlton Vic 9:190\u2013196","journal-title":"Respirology Carlton Vic"},{"key":"425_CR39","doi-asserted-by":"crossref","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2008) EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis [Epub April 15]","DOI":"10.1136\/ard.2008.088096"},{"key":"425_CR40","first-page":"671","volume":"87","author":"Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671\u2013678","journal-title":"QJM"},{"key":"425_CR41","first-page":"31","volume":"55","author":"de","year":"2001","unstructured":"de Groot K, Gross WL, Herlyn K, Reinhold-Keller E (2001) Development and validation of a disease extent index for Wegener\u2019s granulomatosis. Clin Nephrol 55:31\u201338","journal-title":"Clin Nephrol"},{"key":"425_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"Exley","year":"1997","unstructured":"Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the Vasvulitis Damage Index (VDI) for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371\u2013380","journal-title":"Arthritis Rheum"},{"key":"425_CR43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D","volume":"42","author":"Tatsis","year":"1999","unstructured":"Tatsis E, Reinhold-Keller E, Steindorf K et al (1999) Wegener\u2019s granulomatosis associated with renal cell carcinoma. Arthritis Rheum 42:751\u2013756","journal-title":"Arthritis Rheum"},{"key":"425_CR44","first-page":"1584","volume":"28","author":"Choi","year":"2001","unstructured":"Choi HK, Liu S, Merkel PA et al (2001) Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 28:1584\u20131590","journal-title":"J Rheumatol"},{"key":"425_CR45","doi-asserted-by":"crossref","unstructured":"Csernok E, Holle J, Hellmich B et al (2004) Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener\u2019s granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 43:174\u2013180","DOI":"10.1093\/rheumatology\/keh028"},{"key":"425_CR46","first-page":"S1","volume":"25","author":"Hellmich","year":"2007","unstructured":"Hellmich B, Csernok E, Fredenhagen G, Gross WL (2007) A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol 25:S1\u2013S5","journal-title":"Clin Exp Rheumatol"},{"key":"425_CR47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","volume":"147","author":"Finkielman","year":"2007","unstructured":"Finkielman JD, Merkel PA, Schroeder D et al (2007) Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med 147:611\u2013619","journal-title":"Ann Intern Med"},{"key":"425_CR48","first-page":"235","volume":"13","author":"Cordier","year":"1996","unstructured":"Cordier JF (1996) A lung biopsy is unnecessary in the management of ANCA-positive patients with chest-roentgenographic abnormalities. Sarcoidosis Vasc Diffuse Lung Dis 13:235\u2013237","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"425_CR49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00330-002-1403-5","volume":"13","author":"Komocsi","year":"2003","unstructured":"Komocsi A, Reuter M, Heller M et al (2003) Active disease and residual damage in treated Wegener\u2019s granulomatosis: an observational study using pulmonary high-resolution computed tomography. Eur Radiol 13:36\u201342","journal-title":"Eur Radiol"},{"key":"425_CR50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1148\/radiology.213.3.r99dc11794","volume":"213","author":"Murphy","year":"1999","unstructured":"Murphy JM, Gomez-Anson B, Gillard JH et al (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213:794\u2013799","journal-title":"Radiology"},{"key":"425_CR51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s003300050206","volume":"7","author":"Muhle","year":"1997","unstructured":"Muhle C, Reinhold-Keller E, Richter C et al (1997) MRI of the nasal cavity, paranasal sinuses and orbit in Wegener\u2019s granulomatosis. Eur Radiol 7:566\u2013570","journal-title":"Eur Radiol"},{"key":"425_CR52","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1046\/j.1523-1755.2002.00605.x","volume":"62","author":"Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, Van Houwelingen HC et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732\u20131742","journal-title":"Kidney Int"},{"key":"425_CR53","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.2005080870","volume":"17","author":"de","year":"2006","unstructured":"de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264\u20132274","journal-title":"J Am Soc Nephrol"},{"key":"425_CR54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"425_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2249.1995.tb06161.x","volume":"101","author":"Rasmussen","year":"1995","unstructured":"Rasmussen N, Jayne DRW, Abramowicz D et al (1995) European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 101:29\u201334","journal-title":"Clin Exp Immunol"},{"key":"425_CR56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00002281-200101000-00008","volume":"13","author":"Jayne","year":"2001","unstructured":"Jayne D (2001) Update on the European Vasculitis Study Group Trials. Curr Opin Rheumatol 13:48\u201355","journal-title":"Curr Opin Rheumatol"},{"key":"425_CR57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","volume":"43","author":"Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller E, Beuge N, Latza U et al (2000) An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43:1021\u20131032","journal-title":"Arthritis Rheum"},{"key":"425_CR58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","volume":"89","author":"Reinhold-Keller","year":"1996","unstructured":"Reinhold-Keller E, de Groot K, Rudert H et al (1996) Response to trimethroprim-sulfamethoxazole (T\/S) in Wegener\u2019s granulomatosis (WG) depends on the phase of disease. Q J Med 89:15\u201323","journal-title":"Q J Med"},{"key":"425_CR59","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"de","year":"2005","unstructured":"de Groot K, Rasmussen N, Bacon PA et al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52:2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"425_CR60","doi-asserted-by":"crossref","unstructured":"Fauci AS, Wolff SM (1973) Wegener\u2019s granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 52:535\u2013561","DOI":"10.1097\/00005792-197311000-00002"},{"key":"425_CR61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76\u201385","journal-title":"Ann Intern Med"},{"key":"425_CR62","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener\u2019s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"425_CR63","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"de","year":"2001","unstructured":"de Groot K, Adu D, Savage COS (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16:2018\u20132027","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"WGET","year":"2005","unstructured":"WGET Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352:351\u2013361","journal-title":"N Engl J Med"},{"key":"425_CR65","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","volume":"9","author":"Westman","year":"1998","unstructured":"Westman KWA, Bygren PG, Olsson H et al (1998) Relapse rate, renal survival and cancer morbidity in patients with Wegener\u2018 s granulomatosis or microscopic polyangiitis with renal involvement. JASN 9:842\u2013852","journal-title":"JASN"},{"key":"425_CR66","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","volume":"41","author":"Booth","year":"2003","unstructured":"Booth AD, Almond MK, Burns A et al (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776\u2013784","journal-title":"Am J Kidney Dis"},{"key":"425_CR67","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ndt\/gfh161","volume":"19","author":"Weidner","year":"2004","unstructured":"Weidner S, Geuss S, Hafezi-Rachti S et al (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19:1403\u20131411","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR68","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","volume":"40","author":"Pusey","year":"1991","unstructured":"Pusey CD, Rees AJ, Evans DJ et al (1991) Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40:757\u2013763","journal-title":"Kidney Int"},{"key":"425_CR69","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"425_CR70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncpneph0468","volume":"3","author":"Flossmann","year":"2007","unstructured":"Flossmann O, de Groot K (2007) When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy? Nature Clin Prac 3:236\u2013237","journal-title":"Nature Clin Prac"},{"key":"425_CR71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"425_CR72","doi-asserted-by":"crossref","unstructured":"Metzler C, Miehle N, Manger K et al (2007) Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener\u2019s granulomatosis. Rheumatology (Oxford) 46:1087\u20131091","DOI":"10.1093\/rheumatology\/kem029"},{"key":"425_CR73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","volume":"51","author":"Langford","year":"2004","unstructured":"Langford CA, Talar-Williams C, Sneller MC (2004) Mycophenolate mofetil for remission maintenance in the treatment of Wegener\u2019s granulomatosis. Arthritis Rheum 51:278\u2013283","journal-title":"Arthritis Rheum"},{"key":"425_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"Stegeman","year":"1996","unstructured":"Stegeman CA, Cohen Tervaert JW, De Jong PE, Kallenberg CGM (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. N Engl J Med 335:16\u201320","journal-title":"N Engl J Med"},{"key":"425_CR75","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","volume":"58","author":"Pagnoux","year":"2008","unstructured":"Pagnoux C, Hogan SL, Chin H et al (2008) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts. Arthritis Rheum 58:2908\u20132918","journal-title":"Arthritis Rheum"},{"key":"425_CR76","doi-asserted-by":"crossref","first-page":"788A","DOI":"10.1681\/ASN.2006080873","volume":"18","author":"Walsh","year":"2007","unstructured":"Walsh M, Merkel P, Mahr A, Jayne DJ (2007) Systematic review and meta-analysis of relapses in ANCA-associated vasculitis (AAV): What Is the effect of low-dose corticosteroids? J Am Soc Nephrol 18:788A","journal-title":"J Am Soc Nephrol"},{"key":"425_CR77","doi-asserted-by":"crossref","unstructured":"Lapraik C, Watts R, Bacon P et al (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46:1615\u20131616","DOI":"10.1093\/rheumatology\/kem146a"},{"key":"425_CR78","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"Schmitt","year":"2004","unstructured":"Schmitt WH, Hagen EC, Neumann I et al (2004) Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65:1440\u20131448","journal-title":"Kidney Int"},{"key":"425_CR79","doi-asserted-by":"crossref","unstructured":"Lockwood CM, Hale G, Waldman H, Jayne DR (2003) Remission induction in Behcet\u2019s disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H. Rheumatology (Oxford) 42:1539\u20131544","DOI":"10.1093\/rheumatology\/keg424"},{"key":"425_CR80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","volume":"14","author":"Birck","year":"2003","unstructured":"Birck R, Warnatz K, Lorenz HM et al (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14:440\u2013447","journal-title":"J Am Soc Nephrol"},{"key":"425_CR81","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfh763","volume":"20","author":"Schmitt","year":"2005","unstructured":"Schmitt WH, Birck R, Heinzel PA et al (2005) Prolonged treatment of refractory Wegener\u2019s granulomatosis with 15-deoxyspergualin: an open study in seven patients. Nephrol Dial Transplant 20:1083\u20131092","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR82","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ndt\/gfh599","volume":"20","author":"Ferraro","year":"2005","unstructured":"Ferraro A, Day C, Drayson M, Savage C (2005) Effective therapeutic use if rituximab in refractory Wegener\u2019s granulomatosis. Nephrol Dial Transplant 20:622\u2013625","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","volume":"173","author":"Keogh","year":"2006","unstructured":"Keogh KA, Ytterberg SR, Fervenza FC et al (2006) Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173:180\u2013187","journal-title":"Am J Respir Crit Care Med"},{"key":"425_CR84","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","volume":"65","author":"Aries","year":"2006","unstructured":"Aries PM, Hellmich B, Voswinkel J et al (2006) Lack of efficacy of rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 65:853\u2013858","journal-title":"Ann Rheum Dis"},{"key":"425_CR85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/ard.61.6.559","volume":"61","author":"Booth","year":"2002","unstructured":"Booth AD, Jefferson HJ, Ayliffe W et al (2002) Safety and efficacy of TNFalpha blockade in relapsing vasculitis. Ann Rheum Dis 61:559","journal-title":"Ann Rheum Dis"},{"key":"425_CR86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.autrev.2004.06.001","volume":"4","author":"Lamprecht","year":"2005","unstructured":"Lamprecht P (2005) TNF-alpha inhibitors in systemic vasculitides and connective tissue diseases. Autoimmunity reviews 4:28\u201334","journal-title":"Autoimmunity reviews"},{"key":"425_CR87","doi-asserted-by":"crossref","unstructured":"Lamprecht P, Voswinkel J, Lilienthal T et al (2002) Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener\u2019s granulomatosis. Rheumatology (Oxford) 41:1303\u20131307","DOI":"10.1093\/rheumatology\/41.11.1303"},{"key":"425_CR88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.2005.048900","volume":"65","author":"Flossmann","year":"2006","unstructured":"Flossmann O, Jones RB, Jayne DR, Luqmani RA (2006) Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis? Ann Rheum Dis 65:841\u2013844","journal-title":"Ann Rheum Dis"},{"key":"425_CR89","doi-asserted-by":"crossref","unstructured":"Aries PM, Hellmich B, Reinhold-Keller E, Gross WL (2004) High-dose intravenous azathioprine pulse treatment in refractory Wegener\u2019s granulomatosis. Rheumatology (Oxford) 43:1307\u20131308","DOI":"10.1093\/rheumatology\/keh300"},{"key":"425_CR90","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/art.23147","volume":"58","author":"Martinez","year":"2008","unstructured":"Martinez V, Cohen P, Pagnoux C et al (2008) Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum 58:308\u2013317","journal-title":"Arthritis Rheum"},{"key":"425_CR91","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.10459","volume":"47","author":"Reinhold-Keller","year":"2002","unstructured":"Reinhold-Keller E, Fink CO, Herlyn K et al (2002) High rate of renal relapse in 71 patients with Wegener\u2019s granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 47:326\u2013332","journal-title":"Arthritis Rheum"},{"key":"425_CR92","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780380505","volume":"38","author":"Sneller","year":"1995","unstructured":"Sneller MC, Hoffman GS, Talar-Williams C et al (1995) An analysis of forty-two Wegener\u2019s granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 38:608\u2013613","journal-title":"Arthritis Rheum"},{"key":"425_CR93","doi-asserted-by":"crossref","unstructured":"Villa-Forte A, Clark TM, Gomes M et al (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 86:269\u2013277","DOI":"10.1097\/MD.0b013e3181568ec0"},{"key":"425_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","volume":"7","author":"Hogan","year":"1996","unstructured":"Hogan SL, Nachman PH, Wilkman AS et al. (1996) Prognostic markers in patients with anti-neutrophil cytoplasmic autoantibody associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23\u201332","journal-title":"J Am Soc Nephrol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0425-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:07:32Z","timestamp":1738919252000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0425-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}